The Therapeutic Effect of DL-3- n -Butylphthalide in Rats with Chronic Cerebral Hypoperfusion through Downregulation of Amyloid Precursor Protein and Matrix Metalloproteinase-2

Abstract

OBJECTIVE: To investigate the therapeutic effect of DL-3-n-butylphthalide (DL-NBP) in rats with chronic cerebral hypoperfusion. METHODS: Chronic cerebral hypoperfusion was modelled by bilateral permanent occlusion of common carotid arteries in Wistar rats. The therapeutic effect of DL-NBP in hypoperfused rats was evaluated using the Morris water maze task. The levels and deposition of matrix metalloproteinase (MMP) and the amyloid precursor protein β-amyloid 40 (Aβ40) were measured by Western blot analysis and immunohistochemistry in the cerebral cortex and hippocampus. RESULTS: Treatment with DL-NBP significantly improved the learning and memory ability of hypoperfused rats. Western blot analysis indicated that, in comparison with the sham-operated control group, protein levels of Aβ40 and MMP-2 were significantly increased in the cerebral cortex of hypoperfused rats, and treatment with DL-NBP prevented this hypoperfusion-induced increase in Aβ40 and MMP-2. Immunohistochemical analysis showed that Aβ40 and MMP-2 were deposited in venous endothelial cells at day 3 and in arterial endothelial cells at day 14 after hypoperfusion. CONCLUSION: This study indicated that DL-NBP has therapeutic effects on chronic cerebral hypoperfusion and provided a useful insight into the potential molecular mechanisms underlying the therapeutic effect of DL-NBP in chronic cerebral hypoperfusion.

Keywords

CEREBRAL HYPOPERFUSION IMMUNOHISTOCHEMISTRY WESTERN BLOT MATRIX METALLOPROTEINASE AMYLOID PRECURSOR PROTEIN β-AMYLOID 40

References

Chao

Kotsenas

Broderick

: Cerebral amyloid angiopathy: CT and MR imaging findings. Radiographics 2006; 26: 1517–1531.

Vinters

: Cerebral amyloid angiopathy. A critical review. Stroke 1987; 18: 311–324.

Okazaki

Reagan

Campbell

: Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979; 54: 22–31.

de Figueiredo

Oten

: Amyloid deposition in cerebrovascular angiopathy. Ann NY Acad Sci 1997; 826: 463–471.

Huse

Pijak

Leslie

: Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme. J Biol Chem 2000; 275: 33729–33737.

Van Lint

Libert

: Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007; 82: 1375–1381.

Romanic

Madri

: Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 1994; 4: 145–156.

Hamann

Okada

Fitridge

: Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995; 26: 2120–2126.

Hernandez-Guillamon

Mawhirt

Fossati

: Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-β E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells. J Biol Chem 2010; 285: 27144–27158.

10.

Wang

Huang

Tang

: Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia. Acta Pharmacol Sin 2010; 31: 649–664.

11.

Chang

Wang

: Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin 2003; 34: 796–804.

12.

Liu

Feng

: Protective effect of DL-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia. Yao Xue Xue Bao 1995; 30: 896–903 [in Chinese, English abstract].

13.

Peng

Sun

Hon

: L-3-n-Butylphthalide improves cognitive impairment and reduces amyloid-β in a transgenic model of Alzheimer's disease. J Neurosci 2010; 30: 8180–8189.

14.

Feng

Zhang

: Effect of DL-butylphthalide (NBP) on mouse brain energy metabolism in complete brain ischemia induced by decapitation. Yao Xue Xue Bao 1995; 30: 741–744 [in Chinese, English abstract].

15.

Morris

: Developments of water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47–60.

16.

Zipfel

Han

Ford

: Cerebral amyloid antiopathy: progressive disruption of the neurovascular unit. Stroke 2009; 40 (3 suppl): S16–S19.

17.

Davis

Wagner

Zhang

: Amyloid β-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells. J Biol Chem 2003; 278: 19054–19061.

18.

Jung

Zhang

Van Nostrand

: Pathogenic Aβ induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. J Neurochem 2003; 85: 1208–1215.

19.

Ihara

Tomimoto

Kinoshita

: Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J Cereb Blood Flow Metab 2001; 21: 828–834.

20.

Ogle

Zhou

: DL-3-n-Butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway. Brain Res 2010; 1359: 216–226.

21.

Feng

Peng

Liu

: DL-3-n-Butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology 2012; 62: 1004–1010.